Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Noted pharmaceutical industry executive Frederick Beddingfield, MD, PhD, has joined the Neurodon Board of Directors, bringing years of industry leadership.
-
Lilly taps Juvena's AI platform, the first to map the therapeutic potential of secreted proteins, to discover treatments that improve muscle health.
-
Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "The Common Technical Document Training Course" training has been added to ResearchAndMarkets.com's offering. This interactive two-day course will...
-
Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Master Validation Plan - The Unwritten Requirements Course" training has been added to ResearchAndMarkets.com's offering. FDA Warning Letters and...
-
Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance Certification Program" training has been added to ResearchAndMarkets.com's...
-
Ichnos Glenmark Innovation presented full results of TRIgnite-1 study of ISB 2001 at ASCO showing continued high response rate and favorable safety profile
-
33% reduction in relative risk of invasive disease observed in pre-menopausal early breast cancer (EBC) patients receiving Kisqali in 1-year post-treatment analysis1Tolerability remained consistent,...
-
Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia Training Course" has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is...
-
Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Advanced Pharmacovigilance Training Course" training has been added to ResearchAndMarkets.com's offering. This three-day course is designed for those...
-
Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "GCP (Good Clinical Practice) and Clinical Research Update - Hot Inspection Topics Training Course" training has been added to ResearchAndMarkets.com's...